A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel; Olivier Mir; Jennifer Wallet; Isabelle Ray-Coquard; Axel Le Cesne; Antoine Italiano; Sebastien Salas; Corinne Delcambre; Emmanuelle Bompas; François Bertucci; Esma Saada-Bouzid; Loïc Chaigneau; Christine Chevreau; Thomas Brodowicz; Emilie Decoupigny; Marie Vanseymortier; Lucie Laroche; Sophie Taieb; Marie-Cécile Le Deley; Jean-Yves Blay

doi:10.1016/j.ejca.2019.12.001

Journal Articles European Journal of Cancer Year : 2020

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

(1, 2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , , (16) , (16, 18) , (5)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Nicolas Penel

Function : Author
PersonId : 769049
ORCID : 0000-0001-5243-1548
IdRef : 061101109

Université de Lille

Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Olivier Mir

Function : Author
PersonId : 791180
ORCID : 0000-0002-6761-4002
IdRef : 160522498

Institut Gustave Roussy

Jennifer Wallet

Function : Author

Service de Biostatistiques [CHRU Lille]

Isabelle Ray-Coquard

Function : Author
PersonId : 760354
ORCID : 0000-0003-2472-8306

Centre Léon Bérard [Lyon]

Axel Le Cesne

Function : Author
PersonId : 1446728
ORCID : 0000-0002-8006-8659

Département de médecine oncologique [Gustave Roussy]

Antoine Italiano

Function : Author
PersonId : 760314
ORCID : 0000-0002-8540-5351

Université de Bordeaux

Sebastien Salas

Function : Author

Hôpital de la Timone [CHU - APHM]

Corinne Delcambre

Function : Author

Centre Régional de Lutte contre le Cancer François Baclesse [Caen]

Emmanuelle Bompas

Function : Author

Institut de Cancérologie de l'Ouest [Angers/Nantes]

François Bertucci

Function : Author
PersonId : 753650
IdHAL : francois-bertucci
ORCID : 0000-0002-0157-0959

Centre de Recherche en Cancérologie de Marseille

CV

Esma Saada-Bouzid

Function : Author

Medical Oncology Department [Nice]

Loïc Chaigneau

Function : Author

Service d'Oncologie Médicale [CHRU Besançon]

Christine Chevreau

Function : Author

Institut Claudius Regaud

Thomas Brodowicz

Function : Author

Medizinische Universität Wien = Medical University of Vienna

Emilie Decoupigny

Function : Author

Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]

Marie Vanseymortier

Function : Author

Direction de la recherche clinique et de l'innovation [CHU Amiens]

Lucie Laroche

Function : Author

Sophie Taieb

Function : Author

Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]

Marie-Cécile Le Deley

Function : Author

Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]

Centre de recherche en épidémiologie et santé des populations

Jean-Yves Blay

Function : Author
PersonId : 935658
IdHAL : jean-yves-blay
ORCID : 0000-0001-7190-120X
IdRef : 069035407

Centre Léon Bérard [Lyon]

Domains

Cancer

Fichier principal

S0959804919308524.pdf (359.53 Ko)

Origin	Files produced by the author(s)

Accord Elsevier CCSD : Connect in order to contact the contributor

https://amu.hal.science/hal-03623680

Submitted on : Friday, November 29, 2024-4:38:57 PM

Last modification on : Thursday, January 16, 2025-3:19:01 PM

Dates and versions

hal-03623680 , version 1 (29-11-2024)

Licence

Attribution - NonCommercial

Identifiers

HAL Id : hal-03623680 , version 1
DOI : 10.1016/j.ejca.2019.12.001
PII : S0959-8049(19)30852-4

Cite

Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU UNIV-FCOMTE ICR CESP FNCLCC IGR BACLESSE LAMBRET PAOLI_CALMETTES LACASSAGNE ICO UVSQ COMUE-NORMANDIE UNIV-PARIS-SACLAY UNIV-COTEDAZUR UNIV-LILLE CRCM GS-SANTE-PUBLIQUE

153 View

4 Download

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share